2005, BRITISH JOURNAL OF PHARMACOLOGY, Pages 1096-1109 (volume: 146)
Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells (01a Articolo in rivista)
L. Riganti, C. Matteoni, DI ANGELANTONIO Silvia, A. Nistri, A. Gaimarri, F. Sparatore, C. Canu Boido, F. Clementi, C. Gotti
